Search research articles
Contact Us
Filters
Showing results (141-150 of 159) with videos related to
Page
of 16
Sort By:
Surgical Endoscopy
|
March 4, 2026
Developing consensus in post-myotomy dysphagia: a Delphi study integrating anatomic and physiologic assessment from the ACTION group
Shree Patel, Joshua Robertson, William Breaux, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
September 8, 2023
Achieving durable compliance with venous thromboembolism prophylaxis in bariatric surgery: 3-year data from a major academic medical center
Danny Mou, Elissa Falconer, Melissa Majumdar, et al.
Bioorganic Chemistry
|
November 20, 2022
Design, synthesis and biological evaluation of novel pyrazolo-pyrimidin-amines as potent and selective BTK inhibitors
Darshan Joshi, Rajesh Bahekar, Shubhangi Soman, et al.
Journal of Pharmaceutical Sciences
|
October 25, 2019
A Multicompany Assessment of Submicron Particle Levels by NTA and RMM in a Wide Range of Late-Phase Clinical and Commercial Biotechnology-Derived Protein Products
Mario Hubert, Dennis T Yang, Stanley C Kwok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2023
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11
Michael D Jain, David B Miklos, Caron A Jacobson, et al.
Frontiers in Aging Neuroscience
|
May 8, 2026
Limbic-predominant neuroimaging correlates of plasma p-Tau217 in preclinical and clinical Alzheimer's disease
Ankit Patel, William Guiler, Sam Pepper, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 31, 2021
Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B<sup>0</sup>AT1 (SLC6A19)
Jigar Desai, Bhaumin Patel, Brijesh Darji, et al.
The American Journal of Pathology
|
January 24, 2020
miR-218 Expressed in Endothelial Progenitor Cells Contributes to the Development and Repair of the Kidney Microvasculature
Xiaojie Wang, Jialing Liu, Wenqing Yin, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1
Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Pharmacology Research & Perspectives
|
August 14, 2020
ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer
Krishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 159) with videos related to
Sort By:
Page
of 16
Surgical Endoscopy
|
March 4, 2026
Developing consensus in post-myotomy dysphagia: a Delphi study integrating anatomic and physiologic assessment from the ACTION group
Shree Patel, Joshua Robertson, William Breaux, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
September 8, 2023
Achieving durable compliance with venous thromboembolism prophylaxis in bariatric surgery: 3-year data from a major academic medical center
Danny Mou, Elissa Falconer, Melissa Majumdar, et al.
Bioorganic Chemistry
|
November 20, 2022
Design, synthesis and biological evaluation of novel pyrazolo-pyrimidin-amines as potent and selective BTK inhibitors
Darshan Joshi, Rajesh Bahekar, Shubhangi Soman, et al.
Journal of Pharmaceutical Sciences
|
October 25, 2019
A Multicompany Assessment of Submicron Particle Levels by NTA and RMM in a Wide Range of Late-Phase Clinical and Commercial Biotechnology-Derived Protein Products
Mario Hubert, Dennis T Yang, Stanley C Kwok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2023
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11
Michael D Jain, David B Miklos, Caron A Jacobson, et al.
Frontiers in Aging Neuroscience
|
May 8, 2026
Limbic-predominant neuroimaging correlates of plasma p-Tau217 in preclinical and clinical Alzheimer's disease
Ankit Patel, William Guiler, Sam Pepper, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 31, 2021
Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B<sup>0</sup>AT1 (SLC6A19)
Jigar Desai, Bhaumin Patel, Brijesh Darji, et al.
The American Journal of Pathology
|
January 24, 2020
miR-218 Expressed in Endothelial Progenitor Cells Contributes to the Development and Repair of the Kidney Microvasculature
Xiaojie Wang, Jialing Liu, Wenqing Yin, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1
Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Pharmacology Research & Perspectives
|
August 14, 2020
ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer
Krishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani, et al.
Page
of 16